The funding will contribute to advancements in artificial intelligence, clean energy, health care, cybersecurity and more.

A study, co-authored by Stelios Andreadis, is exploring how a gene, called NANOG, can improve the regrowth of damaged nerves and lead to new therapies for severe nerve injuries. 

Multiple Sclerosis News Today reported that a UB study, co-led by Stelios Andreadis, has been awarded $2.9 million to study stem cell therapies for multiple sclerosis (MS). 

MSN.com reported on a project led by Stelios Andreadis to explore a possible solution to why most stem cells die after being injected into the brain, including a technique that injects shear-thinning hydrogels into the brain to protect the injected stem cells. 

Research team uses shear-thinning hydrogels instead of saline solution; could lead to new therapies for MS, other neurological diseases.

The Brighter Side mentions a UB study led by Stelios Andreadis that found that overexpressing a protein called NANOG could help reverse aging in skeleton muscle.

The Chainsaw mentioned research done by Stelios Andreadis, SUNY Distinguished Professor in the Department of Chemical and Biochemical Engineering, that shows aging is a reversible process.